Spencer Barfuss, MD - Medicare Pediatrics in Slc, UT

Spencer Barfuss, MD is a medicare enrolled "Pediatrics - Pediatric Cardiology" physician in Slc, Utah. His current practice location is 81 N Mario Capecchi Dr, Slc, Utah. You can reach out to his office (for appointments etc.) via phone at (801) 213-7609.

Spencer Barfuss is licensed to practice in Utah (license number 10483031-1205) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1972992832.

Contact Information

Spencer Barfuss, MD
81 N Mario Capecchi Dr,
Slc, UT 84113-1125
(801) 213-7609
Not Available



Physician's Profile

Full NameSpencer Barfuss
GenderMale
SpecialityPediatrics - Pediatric Cardiology
Location81 N Mario Capecchi Dr, Slc, Utah
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1972992832
  • Provider Enumeration Date: 01/15/2015
  • Last Update Date: 10/05/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 2567728215
  • Enrollment ID: I20230724001009

Medical Identifiers

Medical identifiers for Spencer Barfuss such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1972992832NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2080P0202XPediatrics - Pediatric Cardiology 10483031-1205 (Utah)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Spencer Barfuss allows following entities to bill medicare on his behalf.
Entity NameIhc Health Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629260880
PECOS PAC ID: 1850209420
Enrollment ID: O20031105000079

News Archive

Sirtex reports 4Q sales growth of 23%

Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

UCLA to study health care disparities affecting minorities

The UCLA Department of Family Medicine, with support from the Robert Wood Johnson Foundation, has launched the Network for Multicultural Research on Health and Healthcare, a group that will study health care disparities affecting minorities with chronic diseases.

Cocaine use by fathers may negatively impact cognitive development in male offspring

Fathers who use cocaine at the time of conceiving a child may be putting their sons at risk of learning disabilities and memory loss.

Read more Medical News

› Verified 4 days ago

Entity NameUniversity Of Utah Pediatric Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1487018974
PECOS PAC ID: 0547552473
Enrollment ID: O20160713000371

News Archive

Sirtex reports 4Q sales growth of 23%

Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

UCLA to study health care disparities affecting minorities

The UCLA Department of Family Medicine, with support from the Robert Wood Johnson Foundation, has launched the Network for Multicultural Research on Health and Healthcare, a group that will study health care disparities affecting minorities with chronic diseases.

Cocaine use by fathers may negatively impact cognitive development in male offspring

Fathers who use cocaine at the time of conceiving a child may be putting their sons at risk of learning disabilities and memory loss.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Spencer Barfuss is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Spencer Barfuss, MD
100 N Mario Capecchi Dr,
Salt Lake City, UT 84113-1103

Ph: () -
Spencer Barfuss, MD
81 N Mario Capecchi Dr,
Slc, UT 84113-1125

Ph: (801) 213-7609

News Archive

Sirtex reports 4Q sales growth of 23%

Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.

Inotek completes two stages of INO-8875 Phase 2b trial against glaucoma

Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

UCLA to study health care disparities affecting minorities

The UCLA Department of Family Medicine, with support from the Robert Wood Johnson Foundation, has launched the Network for Multicultural Research on Health and Healthcare, a group that will study health care disparities affecting minorities with chronic diseases.

Cocaine use by fathers may negatively impact cognitive development in male offspring

Fathers who use cocaine at the time of conceiving a child may be putting their sons at risk of learning disabilities and memory loss.

Read more News

› Verified 4 days ago


Pediatrics Doctors in Slc, UT

Molly A O'gorman, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 100 N Medical Dr, Slc, UT 84113
Phone: 801-588-2000    
Dr. Jared W Henricksen, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 100 Mario Capecchi Dr, Slc, UT 84113
Phone: 801-662-1000    
Dr. Venugopal Amula,
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 100 N Mario Capecchi Dr, Slc, UT 84113
Phone: 806-622-2550    
Dr. Louis Borgenicht, M.D.
Pediatrics
Medicare: Not Enrolled in Medicare
Practice Location: 850 E 300 S Ste 5, Slc, UT 84102
Phone: 801-531-8689    Fax: 801-531-1277
James Thomas, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 295 S Chipeta Way, Slc, UT 84108
Phone: 801-581-4178    Fax: 801-587-7417

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.